Serial #79266874
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79266874 Trademark

Serial Number: 79266874 • Registration: 6138458

Serial #79266874 is a trademark filed by Yangtze River Pharmaceutical (Group) Co., Ltd. on August 8, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Yangtze River Pharmaceutical (Group) Co., Ltd. (9 trademarks)

No.1, South Yangtze River Road
Taizhou, Jiangsu 225300 , CN

Entity Type: 99

Trademark Details

Filing Date

August 8, 2019

Registration Date

September 1, 2020

Published for Opposition

June 16, 2020

Goods & Services

Chemico-pharmaceutical preparations, namely, anti-infectives, pain relief medication, cardiovascular pharmaceuticals, digestives for pharmaceutical purposes, Chinese traditional medicinal herbs, tumor suppressing agents, X-ray contrast agents, pharmaceutical preparations acting on the central nervous system; collyrium; analgesics; medicines for human purposes, namely, anti-infectives, pain relief medication, cardiovascular pharmaceuticals, digestives for pharmaceutical purposes, Chinese traditional medicinal herbs, tumor suppressing agents, X-ray contrast agents, pharmaceutical preparations acting on the central nervous system; medicinal drinks; ointment for pharmaceutical use, namely, medicated ointments for treating dermatological conditions; Chinese medicine nostrum namely, medicinal herbs; adhesive patches for medical use, namely medical plasters; biochemical pharmaceutical preparations, namely, anti-infectives, pain relief medication, cardiovascular pharmaceuticals, digestives for pharmaceutical purposes, Chinese traditional medicinal herbs, tumor suppressing agents, X-ray contrast agents, pharmaceutical preparations acting on the central nervous system; blood for medical use; blood plasma; blood substitutes for human, veterinary use; medicines in form of glue balls, namely anti-infectives, pain relief medication, cardiovascular pharmaceuticals, digestives for pharmaceutical purposes, Chinese traditional medicinal herbs, tumor suppressing agents, X-ray contrast agents, pharmaceutical preparations acting on the central nervous system; medical drinks in the nature of flavored tonic liquors; dietetic foods adapted for medical purposes; depuratives for the body; animal feed additives for medical purpose for use as nutritional supplements; parasiticides; wadding for medical purposes; pharmaceutical preparations to facilitate teething

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Nov 20, 2025 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Sep 1, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 13, 2021 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Dec 22, 2020 XXSS
GENERIC MADRID TRANSACTION CREATED
Dec 21, 2020 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 1, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Sep 1, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 16, 2020 NPUB
PUBLISHED FOR OPPOSITION
Jun 16, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Jun 12, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 27, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 27, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 27, 2020 NONP
ASSIGNED TO LIE
May 12, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
May 8, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 5, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 4, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 4, 2020 TROA
REFUSAL PROCESSED BY IB
Dec 20, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 5, 2019 RFCS
REFUSAL PROCESSED BY MPU
Dec 5, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 14, 2019 RFCR
NON-FINAL ACTION WRITTEN
Nov 13, 2019 CNRT
ASSIGNED TO EXAMINER
Nov 4, 2019 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 20, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 16, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 14, 2019 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Sep 5, 2019 SDRC